News Briefs
America’s National Cancer Institute (NCI) has acknowledged oleocanthal as a potential nutraceutical for breast cancer and awarded $399,999 to the company, Oleolive, for the development of the phenolic compound as a functional food to prevent breast cancer.
The funds will be used to research the preventative and therapeutic benefits of oleocanthal in triple negative breast cancer (TNBC) recurrence. Around 50,000 women in the United States are diagnosed with TNBC annually.
See Also:Health NewsA new, safe and effective recurrence inhibitor is urgently needed as the current outlook for TNBC patients is bleak due to high recurrence rates, poor overall survival rates and ineffective available treatments.
Oleocanthal experts Khalid El Sayed and Amal Kaddoumi, who are the company’s chief scientists and researchers at the University of Louisiana-Monroe, co-authored a 2017 study which revealed that oleocanthal was effective in preventing cancer and Alzheimer’s disease in mice and had the potential to become an effective dietary supplement for reducing the risk of developing both conditions.
El Sayed told Olive Oil Times the nutraceutical will be made available to patients once the team has established the desired potency and efficacy of the oleocanthal formulation for preventing TNBC recurrence. He said that further funding would be sought to prepare the formulation for clinical trials on humans.
“[I would] certainly recommend consumption of high-quality extra virgin olive oil daily for not only breast cancer survivors and patients but also for normal healthy people to maintain a condition of well-being based on the significant positive health outcomes documented by several clinical trials and epidemiological studies,” he said.
His recommendation was an average daily consumption of around 20 to 50 milliliters of olive oil per day, depending on an individual’s health and the quality of olive oil consumed. He advised new consumers of olive oil to start with smaller amounts (five to 10 milliliters) and gradually increase the daily dose over time.
More articles on: breast cancer, cancer prevention, oleocanthal
Apr. 16, 2024
Researchers Investigate Solar Panel and Olive Grove Synergies
Solar panels between rows of high-density olive groves generate electricity with minimal impact on yields.
Jul. 8, 2024
Bricks Made with Olive Pits Reduce Carbon Footprint of Buildings, Study Finds
A new study has shown that olive pit waste can effectively reduce energy usage in buildings, demonstrating how the circular economy can be applied to the construction sector.
Jan. 3, 2024
Promoting the Role of Women in the Olive Sector
Jill Myers founded the Women in Olive Oil network to connect women across the sector while promoting their voices and highlighting their contributions.
Apr. 3, 2024
Uruguay to Host Conference on Olive Oil Sector Research, Innovation
Scientists, producers and officials will meet in Uruguay in November to discuss the challenges and opportunities for South America’s olive oil sector.
Nov. 27, 2023
Mediterranean Diet Helps Slow Age-Related Physical Decline, Study Finds
New research has shown that following a reduced-calorie Mediterranean diet and increasing physical activity slows age-associated muscle loss and reduces total and visceral fat.
May. 28, 2024
Researchers Transform Olive Grove Waste Into Bioplastic
Turning olive tree leaves and branches into biopolymers would provide environmental, economic and social benefits to olive farmers.
Nov. 12, 2024
Olive Leaf Moth Threatens Brazilian Crops: Researchers Seek Solutions
Brazilian researchers have discovered a dual solution to combat the olive leaf moth: a new eco-friendly insecticide and the strategic use of local wasp species as natural predators.
Oct. 18, 2024
Small Study Suggests Anti-Aging Potential of Polyphenols on Skin
Oleocanthal and oleacein significantly reduced wrinkle count in both men and women.